Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

December 31, 2018

Primary Completion Date

September 25, 2020

Study Completion Date

October 6, 2020

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Vibegron

oral administration

DRUG

Placebo

oral administration

Trial Locations (41)

27834

Carolina Digestive Diseases, Greenville

28204

Atrium Healthcare Center for Digestive Health, Charlotte

28546

East Carolina Gastroenterology, Jacksonville

29621

Synexus Clinical Research US, Inc. - Anderson, Anderson

30518

RNA America, LLC, Sugar Hill

32224

Mayo Clinic - Division of Gastroenterology, Jacksonville

33060

Clinical Research Center of Florida, Pompano Beach

33409

Palm Beach Research - ClinEdge - PPDS, West Palm Beach

33777

Florida Center For Gastroenterology, Largo

35211

Synexus Clinical Research US, Inc.-Simon Williamson Clinic, Birmingham

35801

Clinical Research Associates, Huntsville

36693

Alabama Medical Group, PC, Mobile

37404

Chattanooga Medical Research Inc, Chattanooga

38305

Clinical Research Solutions PC, Jackson

45440

Dayton Gastroenterology, Inc., Beavercreek

46268

Investigators Research Group, LLC, Indianapolis

48047

Clinical Research Institute of Michigan, Chesterfield

48109

University of Michigan, Ann Arbor

70471

Mandeville Private Physician Group, LLC, Mandeville

73071

Central Sooner Research, Norman

75044

DHAT Research Institute, Garland

75093

Synexus Clinical Research US, Inc.-Plano, Plano

77030

University of Texas Health Science Center at Houston, Houston

84041

Synexus Clinical Research US, Inc. - Wasatch Peak Family Practice, Layton

84405

Advanced Research Institute, South Ogden

85020

Synexus - Clinical Research Advantage, Inc. - Central Phoenix Medical Clinic LLC, Phoenix

85206

Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC, Mesa

85213

Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC, Mesa

85224

Hope Research Institute, Chandler

Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC, Chandler

89502

Synexus Clinical Research US, Inc. - Rita B. Chuang, MD, LLC, Henderson

89511

Advanced Research Institute, Reno

90045

Southern California Research Institute Medical Group, Inc., Los Angeles

90505

Torrance Clinical Research, Torrance

90822

VA Long Beach Healthcare System - NAVREF, Long Beach

91910

GW Research Inc - ClinEdge-PPDS, Chula Vista

91942

Triwest Research Associates, LLC, La Mesa

92114

Desta Digestive Disease Medical Center, San Diego

92123

Medical Associates Research Group, Inc., San Diego

06518

Medical Research Center of Connecticut LLC, Hamden

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Urovant Sciences GmbH

INDUSTRY

NCT03806127 - Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter